Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic impact of epidermal growth factor receptor mutation in grade 3 stage IA lung adenocarcinomas.

World journal of surgical oncology - 21 May 2026

Jiang Haoyao, Lin Han, Pan Weiyu, Lu Chunlai, Gu Jie, Xu Fengkai, Chen Zongwei, Ma Teng, Ge Di

Abstract excerpt

OBJECTIVES: Stage IA adenocarcinomas (LUAD) with high-risk features exhibited an increased recurrence rate, and the role of adjuvant therapy in this population remains controversial. Our study aimed to evaluate the prognostic impact of epidermal growth factor receptor (EGFR) mutation in grade 3 stage IA LUAD. METHODS: Between 2016 and 2020, 483 consecutive patients undergoing operation, with grade 3 pathologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Follow-Up Studies

Share to Neoplasm Grading

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 42169150
DOI: 10.1186/s12957-026-04411-6
PMCID: PMC13366916

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic impact of epidermal growth factor receptor mutation in grade 3 stage IA lung adenocarcinomas.PMID 42169150Read ↗

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status.Semantic proximity Read ↗

The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.Semantic proximity Read ↗

Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma.Semantic proximity Read ↗

Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgery.Semantic proximity Read ↗

EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.Semantic proximity Read ↗

Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.Semantic proximity Read ↗

EGFR Mutation Impacts Recurrence in High-Risk Early-Stage Lung Adenocarcinoma in the IASLC Grading SystemSemantic proximity Read ↗

Prognostic value of the international association for the study of lung cancer grading system and its association with the tumor microenvironment in stage I EGFR-muted lung adenocarcinoma.Semantic proximity Read ↗

Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma.Semantic proximity Read ↗

The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma.Semantic proximity Read ↗

Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free Survival: A Population-Based Study.Semantic proximity Read ↗

Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.